Rapaflo (silodosin), a new selective alpha-blocker for benign prostatic hyperplasia (BPH)

May 2009

Reps are promoting Rapaflo (silodosin), a new selective alpha-blocker for benign prostatic hyperplasia (BPH).

Think of it as similar to Flomax (tamsulosin).

Rapaflo and Flomax are more selective for alpha receptors that relax the bladder and prostate...instead of lowering blood pressure.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote